BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Day In Review: Biomira Inc. (BIOM) Buys ProlX Pharmaceuticals Corp. For $25.5 Million


10/31/2006 4:45:00 PM

October 31, 2006 -- Biomira bought ProlX Pharmaceuticals, with three cancer drugs in development, for $25.5 million; Avanir received an Approvable letter for Zenvia, which sent the stock lower; CytRx won Orphan Drug designation for its ALS drug candidate in Europe; Adolor returned the rights for the LidoPAIN analgesic patch to EpiCept; Regeneron said Interleukin-1 Trap was effective against a rare genetic disease called CAPS; the US CDC will evaluate a bird flu vaccine from Novovax; Schering began a trial giving lymphoma patients a combination of Leukine and Rituxan; Array will take its anti-inflammatory drug into the clinic; and Introgen will ask for European approval of Advexin p53 therapy for Li-Fraumeni Syndrome. The Centient Biotech 200™ gained 13 points to end at 4001, a rise of .33%. More details...


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES